Total liabilities & equity
Balance – as of period end · $B
Q2 FY2016
5.8$B
All values (45)
| Period | Value ($B) | Status |
|---|---|---|
| Q1 FY2027 | 14.4 | reported |
| Q4 FY2026 | 14.4 | reported |
| Q3 FY2026 | 14.3 | reported |
| Q2 FY2026 | 14.5 | reported |
| Q1 FY2026 | 15.0 | reported |
| Q4 FY2025 | 15.4 | reported |
| Q3 FY2025 | 15.6 | reported |
| Q2 FY2025 | 15.6 | reported |
| Q1 FY2025 | 15.8 | reported |
| Q4 FY2024 | 15.9 | reported |
| Q3 FY2024 | 16.1 | reported |
| Q2 FY2024 | 16.6 | reported |
| Q1 FY2024 | 16.5 | reported |
| Q4 FY2023 | 16.4 | reported |
| Q3 FY2023 | 16.1 | reported |
| Q2 FY2023 | 16.1 | reported |
| Q1 FY2023 | 16.2 | reported |
| Q4 FY2022 | 16.2 | reported |
| Q3 FY2022 | 16.0 | reported |
| Q2 FY2022 | 16.2 | reported |
| Q1 FY2022 | 16.3 | reported |
| Q4 FY2021 | 16.5 | reported |
| Q3 FY2021 | 16.6 | reported |
| Q2 FY2021 | 16.8 | reported |
| Q1 FY2021 | 17.0 | reported |
| Q4 FY2020 | 17.4 | reported |
| Q3 FY2020 | 17.6 | reported |
| Q2 FY2020 | 17.9 | reported |
| Q1 FY2020 | 18.2 | reported |
| Q4 FY2019 | 18.4 | reported |
| Q3 FY2019 | 18.2 | reported |
| Q2 FY2019 | 18.7 | reported |
| Q1 FY2019 | 19.2 | reported |
| Q4 FY2018 | 8.3 | reported |
| Q3 FY2018 | 8.1 | reported |
| Q2 FY2018 | 8.1 | reported |
| Q1 FY2018 | 7.9 | reported |
| Q4 FY2017 | 7.7 | reported |
| Q3 FY2017 | 7.1 | reported |
| Q2 FY2017 | 7.1 | reported |
| Q1 FY2017 | 7.4 | reported |
| Q4 FY2016 | 5.5 | reported |
| Q3 FY2016 | 5.4 | reported |
| Q2 FY2016 | 5.8 | reported |
| Q1 FY2016 | 4.9 | reported |
CSV with all sources · Technical ID: liabilities_and_equity
More metrics for Microchip
Income statement
Balance sheet
Debt and interest
Revenue by segment/product/region
Gross profit by segment
Sources & calculation
- Value
- $5.8B
- Period
- Q2 FY2016, ended Sep 30, 2015 · as of Sep 30, 2015 (balance as of date, not a sum)
- Source
- 10-Q, filed Nov 9, 2015 · 0000827054-15-000218
- Location
- us-gaap:LiabilitiesAndStockholdersEquity
- Confidence
- 1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Versions
| v1 | $5.8B | Nov 9, 2015 | 10-Q 0000827054-15-000218 | reported · confidence 1. · current |